Cantor Fitzgerald adjusted its price target for Palantir Technologies Inc . (NASDAQ:PLTR), increasing it to $98.00 from the previous figure of $72.00. Despite the significant revision, the firm ...
Planet Labs PBC (NYSE:PL – Free Report) had its target price increased by The Goldman Sachs Group from $5.00 to $6.40 in a ...
Stock analysts at Cantor Fitzgerald decreased their FY2025 earnings estimates for shares of Western Digital in a research report issued to clients and investors on Thursday, January 30th. Cantor ...
Tether Holdings Limited announced $13 billion in net profits for 2024, setting records in U.S. Treasury holdings and USDâ‚® ...
PTC Therapeutics (PTCT) is advancing 8% after investment bank Cantor Fitzgerald’ hiked its price target on the drug maker’s ...
U.S. President Donald Trump signed an executive order Monday afternoon charging the Treasury and Commerce Departments with ...
President Donald Trump has nominated 6 people with Long Island ties to cabinet positions — some of whom have been swiftly ...
Will the Senate GOP confirm controversial picks like Tulsi Gabbard and RFK Jr.? Here’s the hearings schedule and list of ...
PLTR stock reports Q4 earnings on Monday. Stock is up 393.36% over past year, 9.71% YTD. Technicals are bullish, but analysts ...
Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on PTC Therapeutics (PTCT – Research Report) today and set a price target of ...
Cantor Fitzgerald raised the firm’s price target on PTC Therapeutics (PTCT) to $113 from $76 and keeps an Overweight rating on the shares. PTC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback